Identification of Hürthle cell cancers: solving a clinical challenge with genomic sequencing and a trio of machine learning algorithms
- Journal
- BMC Systems Biology · vol. 13 · no. Suppl 2 · pp. 27
- Published
- Apr 2019
- Record
- ↗ Journal record
Synopsis
How the Afirma GSC distinguishes benign from cancerous Hürthle cell nodules, a long-standing clinical challenge, using genomic sequencing and an ensemble of three machine learning algorithms. Kennedy is the last author.
In the career genome
- VeracyteChapter 10 · Strand B · PublicationVeracyte, Inc.
Afirma GSC and the Xpression Atlas
Chief Scientific Officer and Chief Medical Officer, Veracyte
MAY 2017 – SEP 2022